SDK-002
/ SkinDermic
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 17, 2026
ATARI-PDAC: ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.
(clinicaltrials.gov)
- P1 | N=10 | Not yet recruiting | Sponsor: Daniel Breadner
New P1 trial • Oncology • Pancreatic Cancer • Pancreatic Ductal Adenocarcinoma
1 to 1
Of
1
Go to page
1